2025year5moon15On the same day, Xie Zhijie, President of the Guangdong Medical Regulatory Science Society, visited and conducted research in the Tailin Life Science Park and Tailin Medical Engineering Park under Tailin Biotechnology. Chu Tuanjie, General Manager of Pharmaceutical Guoxin (Zhejiang) Quality Technology Co., Ltd., accompanied the research. Shen Zhilin, Vice President of Tailin Biology and General Manager of Tailin Life Sciences, Zheng Shuyu, Marketing Director of Tailin Life Sciences, and Chen Junfeng, R&D Director of Tailin Medical Engineering, warmly welcomed the visiting leaders.

President Xie Zhijie, accompanied by General Manager Shen, first visited the Tailin Life Science Product Exhibition Area, R&D Center, Aseptic Laboratory, Physical and Chemical Laboratory, as well as the production areas of bacterial collectors, bacterial incubators, biological indicators, quality control strains, etc. Mr. Shen comprehensively introduced the company's current technological achievements, business layout, development plan, innovative technology application examples, social responsibility, and talent team building to President Xie Zhijie.During her visit to Tailin Biology, President Xie Zhijie highly recognized and appreciated Tailin Biology's rapid development and technological innovation achievements in multiple high-tech fields such as biopharmaceutical consumables, aquatic ecological testing, food safety monitoring, and new materials.

Subsequently, President Xie Zhijie and her delegation visited the Tailin Medical Engineering Park, accompanied by Director Chen, and visited the innovative product display area, pharmaceutical equipment production area, and experimental center. They focused on understanding the sterile production and quality control of drugs, as well as high activity active pharmaceutical ingredients（API）Solutions for production, digitalized microbiology laboratory, etc. President Xie Zhijie encourages enterprises to further focus on innovation driven development, continuously enhance their core competitiveness, and maintain industry advantages.

During the summary discussion, President Xie Zhijie emphasized that Tailin Biology should continue to leverage its advantages in collaborative innovation between industry, academia, and research, and further deepen its strategic cooperation with universities and research institutions.It is recommended that enterprises focus on basic research areas such as water ecosystem health assessment and microbial dynamic monitoring, establish a long-term and systematic scientific research and development mechanism, and build a scientific support system for the development of microbial detection and control technology through the dual wheel drive of data accumulation and technological innovation.We look forward to Tailin Biotechnology continuously innovating its technology while fulfilling its corporate social responsibility, and making greater contributions to the high-quality development of China's biosafety field.

President Xie Zhijie has successively served as the former director of the Zhaoqing Drug Administration in Guangdong Province, the former director of the Guangdong Provincial Drug Inspection Institute, as well as the former director of drug safety and second level inspector of the Guangdong Provincial Drug Administration. Member of the 9th and 10th National Pharmacopoeia Committee, recipient of the National May Day Labor Medal. Engaged in long-term supervision and inspection of drugs and cosmetics, familiar with regulatory standards, regulatory technology, intelligent supervision, risk management, industry development and other regulatory scientific work.